Solvent inclusion in form II carbamazepine
- 20 March 2007
- journal article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- No. 16,p. 1600-1602
- https://doi.org/10.1039/b701299c
Abstract
We report on experimental and theoretical evidence for solvent inclusion in form II carbamazepine (R) and discuss the implications for the formation and stability of this form.Keywords
This publication has 21 references indexed in Scilit:
- Importance of Molecular Shape for the Overall Stability of Hydrogen Bond Motifs in the Crystal Structures of Various Carbamazepine-Type Drug MoleculesCrystal Growth & Design, 2006
- Prediction and Observation of Isostructurality Induced by Solvent Incorporation in Multicomponent CrystalsJournal of the American Chemical Society, 2006
- Amide Pyramidalization in Carbamazepine: A Flexibility Problem in Crystal Structure Prediction?Crystal Growth & Design, 2006
- Comparison of the Four Anhydrous Polymorphs of Carbamazepine and the Crystal Structure of Form I**Supplementary material: X‐ray crystallographic information file (CIF) of triclinic CBZ (form I) is available.Journal of Pharmaceutical Sciences, 2003
- Crystal Engineering of the Composition of Pharmaceutical Phases: Multiple-Component Crystalline Solids Involving CarbamazepineCrystal Growth & Design, 2003
- Single-crystal structure validation with the programPLATONJournal of Applied Crystallography, 2003
- Form IV of CarbamazepineJournal of Pharmaceutical Sciences, 2002
- Physicochemical Properties and X-ray Structural Studies of the Trigonal Polymorph of CarbamazepineJournal of Pharmaceutical Sciences, 1987
- Structure of carbamazepine: 5H-dibenz[b,f]azepine-5-carboxamideActa Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1981
- 5H-Dibenz[b,f]azépinecarboxamide-5 (carbamazépine)Acta Crystallographica Section B: Structural Science, Crystal Engineering and Materials, 1981